• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过诱导DNA双链断裂(DSB),BRCA缺陷型三阴性乳腺癌肿瘤对白花丹醌的敏感性增加。

Increased sensitivity of BRCA defective triple negative breast tumors to plumbagin through induction of DNA Double Strand Breaks (DSB).

作者信息

Nair Rakesh Sathish, Kumar Jerald Mahesh, Jose Jedy, Somasundaram Veena, Hemalatha Sreelatha K, Sengodan Satheesh Kumar, Nadhan Revathy, Anilkumar Thapasimuthu V, Srinivas Priya

机构信息

Cancer Research Program, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, Kerala, India.

Centre for Cellular and Molecular Biology, Hyderabad, India.

出版信息

Sci Rep. 2016 May 25;6:26631. doi: 10.1038/srep26631.

DOI:10.1038/srep26631
PMID:27220670
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4879579/
Abstract

We have earlier shown that Plumbagin (PB) can induce selective cytotoxicity to BRCA1 defective ovarian cancer cells; however, the effect of this molecule in BRCA1 mutated breast cancers has not been analyzed yet. Here, we report that reactive oxygen species (ROS) induced by PB resulted in DNA DSB and activates downstream signaling by ATR/ATM kinases and subsequent apoptosis. PB reduces DNA- dependent protein kinase (DNA-PK) expression and inhibits NHEJ (Non Homologous End Joining) activity in BRCA1 defective breast cancer cells. Also, PB induces apoptosis in two different BRCA1 conditional knock out murine models: MMTV-Cre; BRCA1(Co/Co) and WAP-Cre; BRCA1(Co/Co), at 2 mg/kg body weight, but 32 mg/kg of carboplatin (CN) was needed to induce apoptosis in them. This is the first study where two different tissue specific promoter driven transgenic mice models with BRCA1 exon 11 deletions are used for preclinical drug testing. The apoptosis induced by PB in HR (Homologous Recombination) defective triple negative BRCA1 mutant cell lines and in mouse models occur by inducing ROS mediated DNA DSB. The toxicity profile as compared with CN in transgenic mice provides evidence for PB's safer disposition as a therapeutic lead in breast cancer drug development.

摘要

我们之前已经表明,白花丹醌(PB)可对BRCA1缺陷型卵巢癌细胞诱导选择性细胞毒性;然而,该分子在BRCA1突变型乳腺癌中的作用尚未进行分析。在此,我们报告PB诱导的活性氧(ROS)导致DNA双链断裂(DSB),并通过ATR/ATM激酶激活下游信号传导及随后的细胞凋亡。PB降低BRCA1缺陷型乳腺癌细胞中DNA依赖性蛋白激酶(DNA-PK)的表达并抑制非同源末端连接(NHEJ)活性。此外,PB在两种不同的BRCA1条件性敲除小鼠模型:MMTV-Cre;BRCA1(Co/Co)和WAP-Cre;BRCA1(Co/Co)中,以2mg/kg体重诱导细胞凋亡,但需要32mg/kg的卡铂(CN)才能在其中诱导细胞凋亡。这是首次使用两种不同组织特异性启动子驱动的、带有BRCA1第11外显子缺失的转基因小鼠模型进行临床前药物测试的研究。PB在同源重组(HR)缺陷型三阴性BRCA1突变细胞系和小鼠模型中诱导的细胞凋亡是通过诱导ROS介导的DNA DSB发生的。与转基因小鼠中的CN相比,其毒性特征为PB作为乳腺癌药物开发中的治疗先导提供了更安全处置的证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb00/4879579/13227d9e2189/srep26631-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb00/4879579/a5ce1105d9b5/srep26631-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb00/4879579/ddd962c741f9/srep26631-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb00/4879579/ecaee6605f8d/srep26631-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb00/4879579/1c023081fab3/srep26631-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb00/4879579/13227d9e2189/srep26631-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb00/4879579/a5ce1105d9b5/srep26631-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb00/4879579/ddd962c741f9/srep26631-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb00/4879579/ecaee6605f8d/srep26631-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb00/4879579/1c023081fab3/srep26631-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb00/4879579/13227d9e2189/srep26631-f5.jpg

相似文献

1
Increased sensitivity of BRCA defective triple negative breast tumors to plumbagin through induction of DNA Double Strand Breaks (DSB).通过诱导DNA双链断裂(DSB),BRCA缺陷型三阴性乳腺癌肿瘤对白花丹醌的敏感性增加。
Sci Rep. 2016 May 25;6:26631. doi: 10.1038/srep26631.
2
Molecular trail for the anticancer behavior of a novel copper carbohydrazone complex in BRCA1 mutated breast cancer.新型铜腙配合物在BRCA1突变乳腺癌中抗癌行为的分子轨迹
Mol Carcinog. 2017 May;56(5):1501-1514. doi: 10.1002/mc.22610. Epub 2017 Jan 18.
3
Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy.类似于BRCA1和BRCA2突变型乳腺癌的基因组模式预示着强化的含卡铂化疗的获益。
Breast Cancer Res. 2014 May 15;16(3):R47. doi: 10.1186/bcr3655.
4
Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.通过BRCA1缺陷型乳腺癌干细胞的白花丹醌选择性作用模式。
BMC Cancer. 2016 May 26;16:336. doi: 10.1186/s12885-016-2372-4.
5
Plumbagin, a naphthaquinone derivative induces apoptosis in BRCA 1/2 defective castrate resistant prostate cancer cells as well as prostate cancer stem-like cells.白花丹醌是一种萘醌衍生物,能诱导 BRCA1/2 缺陷型去势抵抗性前列腺癌细胞以及前列腺癌干细胞样细胞发生凋亡。
Pharmacol Res. 2016 Mar;105:134-45. doi: 10.1016/j.phrs.2016.01.012. Epub 2016 Jan 22.
6
Targeting aberrant DNA double-strand break repair in triple-negative breast cancer with alpha-particle emitter radiolabeled anti-EGFR antibody.用α粒子发射体放射性标记的抗 EGFR 抗体靶向三阴性乳腺癌中的异常 DNA 双链断裂修复。
Mol Cancer Ther. 2013 Oct;12(10):2043-54. doi: 10.1158/1535-7163.MCT-13-0108. Epub 2013 Jul 19.
7
mTOR Inhibitors Suppress Homologous Recombination Repair and Synergize with PARP Inhibitors via Regulating SUV39H1 in BRCA-Proficient Triple-Negative Breast Cancer.mTOR抑制剂抑制同源重组修复,并通过调控BRCA功能正常的三阴性乳腺癌中的SUV39H1与PARP抑制剂协同作用。
Clin Cancer Res. 2016 Apr 1;22(7):1699-712. doi: 10.1158/1078-0432.CCR-15-1772. Epub 2015 Nov 6.
8
Ataxia telangiectasia mutated and checkpoint kinase 2 regulate BRCA1 to promote the fidelity of DNA end-joining.共济失调毛细血管扩张症突变蛋白和关卡激酶2调节乳腺癌1号基因以提高DNA末端连接的准确性。
Cancer Res. 2006 Feb 1;66(3):1391-400. doi: 10.1158/0008-5472.CAN-05-3270.
9
Synthetically Lethal BMN 673 (Talazoparib) Loaded Solid Lipid Nanoparticles for BRCA1 Mutant Triple Negative Breast Cancer.载合成致死剂 BMN 673(他拉唑帕利)的固体脂质纳米粒用于 BRCA1 突变型三阴性乳腺癌。
Pharm Res. 2018 Sep 25;35(11):218. doi: 10.1007/s11095-018-2502-6.
10
The combination of thymoquinone and paclitaxel shows anti-tumor activity through the interplay with apoptosis network in triple-negative breast cancer.百里醌与紫杉醇联合使用通过与三阴性乳腺癌细胞凋亡网络相互作用发挥抗肿瘤活性。
Tumour Biol. 2016 Apr;37(4):4467-77. doi: 10.1007/s13277-015-4307-0. Epub 2015 Oct 26.

引用本文的文献

1
Different Derivatives of Plumbagin Analogue: Bioavailability and Their Toxicity Studies.白花丹素类似物的不同衍生物:生物利用度及其毒性研究
Food Sci Nutr. 2025 Aug 19;13(8):e70720. doi: 10.1002/fsn3.70720. eCollection 2025 Aug.
2
Association between single nucleotide polymorphisms of DNA repair genes (BRCA1, BRCA2, and PALB2) and breast cancer incidence in a subset of Iranian population.伊朗部分人群中DNA修复基因(BRCA1、BRCA2和PALB2)单核苷酸多态性与乳腺癌发病率之间的关联。
Hered Cancer Clin Pract. 2025 Mar 29;23(1):12. doi: 10.1186/s13053-025-00311-0.
3
Anticancer Effects and Mechanisms of Action of Plumbagin: Review of Research Advances.

本文引用的文献

1
Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation.奥拉帕利单药治疗携带胚系 BRCA1/2 突变的晚期癌症患者。
J Clin Oncol. 2015 Jan 20;33(3):244-50. doi: 10.1200/JCO.2014.56.2728. Epub 2014 Nov 3.
2
Functional deficiency of NBN, the Nijmegen breakage syndrome protein, in a p.R215W mutant breast cancer cell line.在一种p.R215W突变的乳腺癌细胞系中,Nijmegen断裂综合征蛋白NBN的功能缺陷。
BMC Cancer. 2014 Jun 13;14:434. doi: 10.1186/1471-2407-14-434.
3
BRCA1 and Oxidative Stress.BRCA1 与氧化应激。
白花丹素的抗癌作用及其作用机制:研究进展综述。
Biomed Res Int. 2020 Dec 1;2020:6940953. doi: 10.1155/2020/6940953. eCollection 2020.
4
Perspectives on mechanistic implications of ROS inducers for targeting viral infections.ROS 诱导剂在靶向病毒感染方面的机制影响的观点。
Eur J Pharmacol. 2021 Jan 5;890:173621. doi: 10.1016/j.ejphar.2020.173621. Epub 2020 Oct 14.
5
BRCA1 promoter hypermethylation in human placenta: a hidden link with β-hCG expression.人类胎盘中 BRCA1 启动子超甲基化:与β-hCG 表达的隐藏联系。
Carcinogenesis. 2020 Jul 10;41(5):611-624. doi: 10.1093/carcin/bgz117.
6
β-hCG-induced mutant BRCA1 ignites drug resistance in susceptible breast tissue.β-hCG 诱导的突变 BRCA1 引发敏感乳腺组织中的药物耐药性。
Carcinogenesis. 2019 Nov 25;40(11):1415-1426. doi: 10.1093/carcin/bgz070.
7
Plumbagin Ameliorates Collagen-Induced Arthritis by Regulating Treg/Th17 Cell Imbalances and Suppressing Osteoclastogenesis.白花丹素通过调节 Treg/Th17 细胞失衡和抑制破骨细胞生成来改善胶原诱导性关节炎。
Front Immunol. 2019 Jan 8;9:3102. doi: 10.3389/fimmu.2018.03102. eCollection 2018.
8
Curcumin induces G2/M cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and through ATM/Chk2/p53-dependent pathway.姜黄素通过ATM/Chk2/p53依赖途径诱导头颈部鳞状细胞癌的G2/M期细胞周期阻滞和凋亡。
Oncotarget. 2017 Apr 13;8(31):50747-50760. doi: 10.18632/oncotarget.17096. eCollection 2017 Aug 1.
9
BRCA1 regulation on β-hCG: a mechanism for tumorigenicity in BRCA1 defective breast cancer.BRCA1对β-人绒毛膜促性腺激素的调控:BRCA1缺陷型乳腺癌的致瘤机制
Oncogenesis. 2017 Sep 4;6(9):e376. doi: 10.1038/oncsis.2017.75.
Cancers (Basel). 2014 Apr 3;6(2):771-95. doi: 10.3390/cancers6020771.
4
Cancer suppression by the chromosome custodians, BRCA1 and BRCA2.染色体守护者 BRCA1 和 BRCA2 的抑癌作用。
Science. 2014 Mar 28;343(6178):1470-5. doi: 10.1126/science.1252230.
5
BRCA 1/2-Mutation Related and Sporadic Breast and Ovarian Cancers: More Alike than Different.BRCA 1/2基因变异相关及散发性乳腺癌和卵巢癌:相似之处多于不同之处。
Front Oncol. 2014 Feb 27;4:19. doi: 10.3389/fonc.2014.00019. eCollection 2014.
6
The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance.DNA 损伤信号失调对癌症化疗反应和耐药性的影响。
Nat Rev Cancer. 2012 Sep;12(9):587-98. doi: 10.1038/nrc3342.
7
FOXO3 signalling links ATM to the p53 apoptotic pathway following DNA damage.FOXO3 信号通路将 ATM 与 DNA 损伤后的 p53 凋亡途径相连接。
Nat Commun. 2012;3:1000. doi: 10.1038/ncomms2008.
8
Structure activity relationship of plumbagin in BRCA1 related cancer cells.BRCA1 相关癌细胞中白花丹醌的构效关系。
Mol Carcinog. 2013 May;52(5):392-403. doi: 10.1002/mc.21877. Epub 2012 Jan 30.
9
DNA damage induces reactive oxygen species generation through the H2AX-Nox1/Rac1 pathway.DNA 损伤通过 H2AX-Nox1/Rac1 途径诱导活性氧的产生。
Cell Death Dis. 2012 Jan 12;3(1):e249. doi: 10.1038/cddis.2011.134.
10
Plumbagin inhibits cell growth and potentiates apoptosis in human gastric cancer cells in vitro through the NF-κB signaling pathway.白花丹素通过 NF-κB 信号通路抑制体外人胃癌细胞的生长并促进其凋亡。
Acta Pharmacol Sin. 2012 Feb;33(2):242-9. doi: 10.1038/aps.2011.152. Epub 2012 Jan 9.